Characterization of a proteolytically stable multifunctional host defense peptidomimetic

Chemistry and Biology

Volumn 20, Issue 10, 2013, Pages 1286-1295

  Jahnsen, Rasmus D ^a,b   Haney, Evan F ^b   Franzyk, Henrik ^a   Hancock, Robert E W ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; GENTAMICIN; HDM 4; IMIPENEM; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PEPTIDOMIMETIC AGENT; POLYMYXIN B; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; HOST RESISTANCE; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ANTI-INFECTIVE AGENTS; BIOFILMS; CELL MEMBRANE; DNA; ESCHERICHIA COLI O157; HUMANS; IMMUNOMODULATION; INFLAMMATION; KINETICS; LIPOPOLYSACCHARIDES; PEPTIDOMIMETICS; PROTEIN STABILITY; PROTEOLYSIS;

EID: 84886797920     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.09.007     Document Type: Article

References (45)

1. L.A. Arroyo, C.M. Herrera, L. Fernandez, J.V. Hankins, M.S. Trent, and R.E.W. Hancock The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A Antimicrob. Agents Chemother. 55 2011 3743 3751
2. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, and J. Bartlett Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin. Infect. Dis. 48 2009 1 12
3. D.M.E. Bowdish, D.J. Davidson, and R.E.W. Hancock A re-evaluation of the role of host defence peptides in mammalian immunity Curr. Protein Pept. Sci. 6 2005 35 51
4. K.A. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3 2005 238 250
5. N. Chongsiriwatana, and A. Barron Comparing bacterial membrane interactions of antimicrobial peptides and their mimics Methods Mol Biol. 618 2010 171 182
6. D. Clark Novel antibiotic hypersensitive mutants of Escherichia coli genetic mapping and chemical characterization FEMS Microbiol. Lett. 21 1984 189 195
7. J.W. Costerton, P.S. Stewart, and E.P. Greenberg Bacterial biofilms: a common cause of persistent infections Science 284 1999 1318 1322
8. M.G. Davies, and P.O. Hagen Systemic inflammatory response syndrome Br. J. Surg. 84 1997 920 935
9. C. de la Fuente-Núñez, V. Korolik, M. Bains, U. Nguyen, E.B.M. Breidenstein, S. Horsman, S. Lewenza, L. Burrows, and R.E.W. Hancock Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide Antimicrob. Agents Chemother. 56 2012 2696 2704
10. T. Decker, and M.-L. Lohmann-Matthes A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity J. Immunol. Methods 115 1988 61 69
11. R.M. Donlan Biofilm formation: a clinically relevant microbiological process Clin. Infect. Dis. 33 2001 1387 1392
12. P.I. Fields, E.A. Groisman, and F. Heffron A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells Science 243 1989 1059 1062
13. C.D. Fjell, J.A. Hiss, R.E.W. Hancock, and G. Schneider Designing antimicrobial peptides: form follows function Nat. Rev. Drug Discov. 11 2012 37 51
14. R.L. Gallo, K.J. Kim, M. Bernfield, C.A. Kozak, M. Zanetti, L. Merluzzi, and R. Gennaro Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse J. Biol. Chem. 272 1997 13088 13093
15. J.D. Hale, and R.E.W. Hancock Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti-Infect. 5 2007 951 959
16. R.E.W. Hancock, and P.G. Wong Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane Antimicrob. Agents Chemother. 26 1984 48 52
17. R.E.W. Hancock, and H.G. Sahl Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat. Biotechnol. 24 2006 1551 1557
18. R.E.W. Hancock, S.W. Farmer, Z.S. Li, and K. Poole Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli Antimicrob. Agents Chemother. 35 1991 1309 1314
19. E.F. Haney, A.P. Petersen, C.K. Lau, W. Jing, D.G. Storey, and H.J. Vogel Mechanism of action of puroindoline derived tryptophan-rich antimicrobial peptides Biochim. Biophys. Acta 1828 2013 1802 1813
20. K. Hilpert, R. Volkmer-Engert, T. Walter, and R.E.W. Hancock High-throughput generation of small antibacterial peptides with improved activity Nat. Biotechnol. 23 2005 1008 1012
21. C.C. HsuChen, and D.S. Feingold The mechanism of polymyxin B action and selectivity toward biologic membranes Biochemistry 12 1973 2105 2111
22. D. Jabes The antibiotic R&D pipeline: an update Curr. Opin. Microbiol. 14 2011 564 569
23. R.D. Jahnsen, N. Frimodt-Møller, and H. Franzyk Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones J. Med. Chem. 55 2012 7253 7261
24. R. Kapoor, M.W. Wadman, M.T. Dohm, A.M. Czyzewski, A.M. Spormann, and A.E. Barron Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 55 2011 3054 3057
25. N.T. Liberati, J.M. Urbach, S. Miyata, D.G. Lee, E. Drenkard, G. Wu, J. Villanueva, T. Wei, and F.M. Ausubel An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants Proc. Natl. Acad. Sci. USA 103 2006 2833 2838
26. Y. Liu, K.M. Knapp, L. Yang, S. Molin, H. Franzyk, and A. Folkesson High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis Int. J. Antimicrob. Agents 41 2013 20 27
27. B. Loh, C. Grant, and R.E.W. Hancock Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa Antimicrob. Agents Chemother. 26 1984 546 551
28. N. Mookherjee, and R.E.W. Hancock Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections Cell. Mol. Life Sci. 64 2007 922 933
29. N. Mookherjee, K.L. Brown, D.M.E. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F.M. Roche, R.X. Mu, G.H. Doho, and J. Pistolic Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37 J. Immunol. 176 2006 2455 2464
30. R.A. Moore, N.C. Bates, and R.E.W. Hancock Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin Antimicrob. Agents Chemother. 29 1986 496 500
31. J. Oteo, M. Pérez-Vázquez, and J. Campos Extended-spectrum [β]-lactamase producing Escherichia coli: changing epidemiology and clinical impact Curr. Opin. Infect. Dis. 23 2010 320 326
32. M.R. Parsek, and P.K. Singh Bacterial biofilms: an emerging link to disease pathogenesis Annu. Rev. Microbiol. 57 2003 677 701
33. A. Peschel, and H.-G. Sahl The co-evolution of host cationic antimicrobial peptides and microbial resistance Nat. Rev. Microbiol. 4 2006 529 536
34. B. Pitts, M.A. Hamilton, N. Zelver, and P.S. Stewart A microtiter-plate screening method for biofilm disinfection and removal J. Microbiol. Methods 54 2003 269 276
35. U. Römling, and C. Balsalobre Biofilm infections, their resilience to therapy and innovative treatment strategies J. Intern. Med. 272 2012 541 561
36. M.G. Scott, A.C.E. Vreugdenhil, W.A. Buurman, R.E.W. Hancock, and M.R. Gold Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein J. Immunol. 164 2000 549 553
37. M.G. Scott, D.J. Davidson, M.R. Gold, D. Bowdish, and R.E.W. Hancock The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses J. Immunol. 169 2002 3883 3891
38. M.G. Scott, E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A.K. Wang, K. Lee, S. Doria, and P. Hamill An anti-infective peptide that selectively modulates the innate immune response Nat. Biotechnol. 25 2007 465 472
39. M. Sieprawska-Lupa, P. Mydel, K. Krawczyk, K. Wójcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, and J. Pohl Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases Antimicrob. Agents Chemother. 48 2004 4673 4679
40. P.K. Singh, A.L. Schaefer, M.R. Parsek, T.O. Moninger, M.J. Welsh, and E.P. Greenberg Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms Nature 407 2000 762 764
41. D.R. Storm, K.S. Rosenthal, and P.E. Swanson Polymyxin and related peptide antibiotics Annu. Rev. Biochem. 46 1977 723 763
42. U. Theuretzbacher Global antibacterial resistance: The never-ending story J. Global Antibiot. Res. 1 2013 63 69
43. E. Turner-Brannen, K.Y. Choi, D.N.D. Lippert, J.P. Cortens, R.E.W. Hancock, H. El-Gabalawy, and N. Mookherjee Modulation of interleukin-1β- induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts Arthritis Res. Ther. 13 2011 R129
44. M. Wieczorek, H. Jenssen, J. Kindrachuk, W.R.P. Scott, M. Elliott, K. Hilpert, J.T.J. Cheng, R.E.W. Hancock, and S.K. Straus Structural studies of a peptide with immune modulating and direct antimicrobial activity Chem. Biol. 17 2010 970 980
45. M. Wu, E. Maier, R. Benz, and R.E.W. Hancock Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli Biochemistry 38 1999 7235 7242